A substantial proportion of patients with recurrent implantation failure treated with partner lymphocyte immunotherapy achieved live birth within 3 years after immunization.

Obstet Gynecol Sci · 2026 · PMC13408300 · PMID 42403309

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a nonsignificant trendP =0.12not close (p > 0.1)

However, women who received ASA showed a nonsignificant trend toward achieving a live birth after LIT ( P =0.12; Table 3 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.